期刊文献+

环孢素A纳米粒滴眼液抑制大鼠高危角膜移植免疫排斥反应的实验研究 被引量:1

Cyclosporine A nano-particle eye drops prevent the high risk corneal transplantation immune rejection in rats
原文传递
导出
摘要 目的探讨环孢素A纳米粒滴眼液对大鼠高危角膜移植术后排斥反应的抑制作用。设计实验研究。研究对象Lewis大鼠50只为受体,F344大鼠25只为供体。方法 50只Lewis大鼠右眼采用缝线法诱导角膜新生血管形成,第7天新生血管到达角膜中周部时,全部行穿透性角膜移植术。因术后滴眼液不同将大鼠随机分为5组(A到E组,每组10只大鼠),A组为对照组,给予环孢素A纳米粒滴眼液的基质点药,B组为普通环孢素A滴眼液组,C组、D组、E组分别为0.5%、1%、2%环孢素A纳米粒滴眼液组。术后各组滴用相应的滴眼液,每日3次。拍摄大鼠角膜照片每日1次至14天,以后每2日拍摄角膜照片1次至28天。以角膜植片水肿、混浊、新生血管评分之和为角膜排斥反应指数(RI),记录角膜存活时间(从角膜移植开始到RI=6的时间),术后第14天每组取2只大鼠眼球,以光镜进行角膜病理学观察。主要指标角膜植片存活时间、角膜排斥反应指数(RI),角膜的病理学改变。结果 A到E组角膜存活时间分别为(7.20±2.93)天、(10.89±3.62)天、(10.50±3.40)天、(11.13±3.94)天和(12.80±4.07)天,各组间比较差异有统计学意义(F=3.20,P=0.022)。B、C、D、E组与A组相比,角膜存活时间明显延长,差异均有统计学意义(P=0.031、0.047、0.027、0.001)。B组与C、D、E组之间比较差异均无统计学意义(P=0.815、0.853、0.255),C组与D、E组之间差异均无统计学意义(P=0.716、0.161),D组与E组之间差异无统计学意义(P=0.333)。A到E组RI分别为7.80±1.48、5.67±1.80、6.10±1.66、5.25±1.75和4.80±1.23,组间比较差异具有统计学意义(F=5.202,P=0.002)。B、C、D、E组与A组相比,RI明显减小,差异有统计学意义(P=0.005、0.021、0.002、0.000)。B组与C、D、E组比较差异均无统计学意义(P=0.555、0.592、0.241)。C组与D、E组比较差异无统计学意义(P=0.265、0.074)。D组与E组之间差异无统计学意义(P=0.553)。A组角膜植片明显水肿、增厚,基质层可见大量细胞浸润,细胞排列紊乱。B^E组角膜基质层浸润程度较A组明显减轻。结论普通环孢素滴眼液组及高、中、低浓度的环孢素A纳米粒滴眼液均能有效地抑制高危角膜移植术后的排斥反应。 Objective To investigate the preventing effect of cyclosporine A nano-particle eye drops on immune rejection after high risk corneal transplantation.Design Experimental study.Participants Fifty Lewis rats as receptor and twenty-five F344 rats as donator.Method Corneal neoangiogenesis was induced by suture method.Rats were divided into 5 groups(group A to E).All the animals underwent corneal penetrating transplantation in right eyes at 7th day after suturing when the new vascular appeared in the middle part of the cornea.The cornea donator were F344 rats.Group A received vehicle eye drops,group B received cyclosporine A eye drops,group C to E received 0.5%,1% and 2% cyclosporine A nano-particle eye drops respectively.All animals were received the eye drops 3 times a day.Cornea was observed by slit lamp everyday within 14 days and photographs were taken.Then the cornea was observed every two days until 28 days.The cornea was studied pathologically at day 14 for 2 rats each group.Main Outcome Measures Cornea survival time(from corner transplantation to the time when RI equals 6),rejection index(RI),pathologically observation of cornea at day 14.Results The mean survival time from group A to E were 7.20±2.93 days,10.89±3.62 days,10.50±3.40 days,11.13±3.94 days and 12.80±4.07 days respectively.Significant difference was found among groups(F=3.20,P=0.022).The survival time at any group from B to E was significantly longer than group A(P value was 0.031,0.047,0.027,0.001 respectively).No significant difference was found between group B and any group from C to E(P value was 0.815,0.853,0.255 respectively).No significant difference was found between group C and group D or group E(P value was 0.716,0.161 respectively).No significant difference was found between group D and group E(P = 0.333).RI from group A to E were 7.80±1.48,5.67±1.80,6.10±1.66,5.25±1.75 and 4.80±1.23 respectively.Significant difference was found between them(F=5.202,P=0.002).The RI at any group from B to E was lower than group A(P value was 0.005,0.021,0.002,0.000 respectively).No significant difference was found between group B and any group from C to E(P value was 0.555,0.592,0.241 respectively).No significant difference was found between group C and group D or group E(P value was 0.265,0.074 respectively).No significant difference was found between group D and group E(P=0.553).The cornea was obviously edematous,thickening,and showing cell infiltration in group A.The cornea cells showed layer disorder in group A.The degree of cornea infiltration was lighter in group B to E than in group A.Conclusion Cyclosporine A nino-particle eye drops of high,middle,low concentration and ordinary Cyclosporine A eye drops can effectively prevent cornea immune rejection after high risk cornea transplantation.
出处 《眼科》 CAS 2012年第2期116-120,共5页 Ophthalmology in China
基金 北京市科技计划课题资助项目(Z09050700620908) 十二五重大新药创制国家科技重大专项(20112X09302-007-05)
关键词 角膜移植 免疫排斥 环孢素A 纳米粒滴眼液 corneal transplantation immune rejection cyclosporine A nano-particle eye drops
  • 相关文献

参考文献11

  • 1史伟云,谢立信.高危角膜移植[J].中国实用眼科杂志,1998,16(12):712-714. 被引量:16
  • 2Campos AM,Sanchez A,Alonso MJ.Chitosan nanoparticles:a newvehicle for the improvement of the delivery of drugs to the ovularsurface.Application to cyclosporin A.Inter J Pharm,2001,224:159-168.
  • 3Yan W,Mingjun L,Hongxia G.Polymeric micelle composed of PLA and chitosan as a drug carrier.J Polym Res,2009,16:11-18.
  • 4王颖,马东丽,接英,潘志强,徐健,武宇影.中药菊花决明散防治大鼠高危角膜移植免疫排斥反应的研究[J].中国中西医结合杂志,2010,30(2):178-181. 被引量:6
  • 5接英,张文华,潘志强,徐亮,武宇影,王颖.白介素-1受体拮抗剂滴眼液治疗大鼠高危角膜移植免疫排斥反应[J].眼科研究,2004,22(5):463-466. 被引量:4
  • 6Holland EJ,Chan CC,Wetzig RP,et al.Clinical and immunohisto-logic studies of corneal rejection in the rat penetrationg kerato-plasty model.Cornea,1991,10:374-380.
  • 7张文华,潘志强,翟长斌,武宇影,刘海霞,李辽青,李纳,邹留河.国产环孢素A眼液治疗大鼠角膜移植术后免疫排斥反应的研究[J].中华眼科杂志,2001,37(2):140-143. 被引量:13
  • 8Utine CA,Strn M,Akpek EK.Clinical review:topical ophthalmicuse of cyclosporin A.Ocul Immu Inflam,2010,18:352-361.
  • 9Lee SS,Kim H,Wang NS,et al.A pharmacokinetic and safety e-valuation of an episcleral cyclosporine implant for potential use inhigh-risk keratoplasty rejection.Invest Ophthalmol Vis Sci,2007,48:2023-2029.
  • 10Stevenson D,Tauber J,Reis BL,et al.Efficacy and safety of cy-closporine A ophthalmic emulsion in the treatment of moder-ate-to-severe dry eye disease:a dose-ranging,randomized trial.The Cyclosporin A Phase 2 Study Group.Ophthalmology,2000,107:967-974.

二级参考文献14

  • 1De-Sheng Wang,Yu Li,Ke-Feng Dou,Kai-Zong Li,Zhen-Shun Song.Utility of adenovirus-mediated Fas ligand and bcl-2 gene transfer to modulate rat liver allograft survival[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):505-510. 被引量:6
  • 2谢立信.眼前段碱性化学伤的后期治疗(一)[J].眼外伤职业眼病杂志,1994,16(3):237-239. 被引量:4
  • 3吕岚,王荣光,邹留河,董东生.圆锥角膜穿透性角膜移植术前后的角膜地形图分析[J].中华眼科杂志,1998,34(2):156-157. 被引量:2
  • 4Holland EJ,Chan CC,Wetzig RP,et al.Clinical and immuno-histologic studies of corneal rejection in the rat penetrating keratoplasty model[J].Cornea,1991,10:374-380
  • 5Masahiko S,Peter JP,Michael BB.Pathways for lipid antigen presentation by CD1 molecules:nowhere for intracellular pathogens to hide[J].Traffic,2002,1:295-300
  • 6Lucia K,Vladimir H,Lynne L,et al.Cell subpopulations in failed human corneal grafts[J].Br J Ophthalmol,1999,83:1364-1369
  • 7Williams KA,Muehiberg SM,Lewis RF,et al.How successful is corneal transplantation?A report from the Australian corneal graft register[J].Eye,1995,9:219-227
  • 8Dana MR,Yamada J,Streilein JW.Topical interleunkin1 receptor antagonist promotes corneal transplant survival[J].Transplantation,1997,63:1501-1507
  • 9谢立信,董晓光,张杰.穿透性角膜移植术植片混浊的发生规律探讨[J]眼科新进展,1987(03).
  • 10史伟云,谢立信.高危角膜移植[J].中国实用眼科杂志,1998,16(12):712-714. 被引量:16

共引文献35

同被引文献17

  • 1谢立信,曹景,董晓光,杨雪萍.环孢霉素A和地塞米松局部应用对角膜移植免疫排斥的疗效观察[J].眼科研究,1995,13(1):24-26. 被引量:8
  • 2周晓洁,孔丽萍,张秀华,黄学荪,张春红.环孢素A滴眼液防治兔角膜移植术后的免疫排斥反应[J].中国新药杂志,2006,15(12):977-979. 被引量:6
  • 3Tabbara KF. Pharmacologic strategies in the prevention and treatment ofcorneal transplant rejection [ J ]. Int Ophthalmol,2008,28 : 223 -232.
  • 4Bailly N, Dunewa I,Schlattmann P, et al. Significance of cyclosporin A absorption for effective immuno modulatory therapy after high-risk keratoplasty [ J ]. Ophthalmologe, 2008,105 : 457 -462.
  • 5di Tommaso C, Bourges JL, Valamanesh F, et al. Novel micelle carriers for cyelosporin A topical ocular delivery:in vivo cornea penetration, ocular distribution and efficacy studies [ J ]. Eur J Pharm Biopharm, 2012.81 : 257-264.
  • 6Gebhardt BM, Varnell ED, Kaufman HE. Cyclosporine in collagen particles:corneal penetration and suppression of allograft rejection[ J ]. J Ocul Pharmacol Ther, 1995,11 : 509-517.
  • 7Shen J, Deng Y, Jin X, et al. Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A:Improving in vivo ocular distribution[ J]. [nt J Pharm ,2010,402 : 248-253.
  • 8Holland E J, Chan CC, Wetzig RP, et al. Clinical and immunohistologic studies of corneal rejection in the rat penetrating keratoplasty model [ J ]. Cornea, 1991,10 : 374- 380.
  • 9de Campos AM, S6nehez A, Alonso MJ. Chitosaa nanoparticl.es: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A [ J ]. Int J Pharm, 2001,224 : 159-168.
  • 10BenEzra D ,Maftzir G ,de Courten C ,et al. Ocular penetration of cyclosporin A. Ill : The human eye [ J ]. Br J Ophthalmol, 1990,74 : 350-352.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部